ORGN vs BAK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

ORGN

53.7
AI Score
VS
ORGN Wins

BAK

29.5
AI Score

Investment Advisor Scores

ORGN

54score
Recommendation
HOLD

BAK

30score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ORGN BAK Winner
Forward P/E 0 9.7847 Tie
PEG Ratio 0 1.4567 Tie
Revenue Growth -91.2% 21.6% BAK
Earnings Growth 266.7% 107.2% ORGN
Tradestie Score 53.7/100 29.5/100 ORGN
Profit Margin 0.0% -7.8% ORGN
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY ORGN

Relative Price Performance (Last 90 Days)

ORGN 1M: -32.1% · 3M: -58.3% BAK 1M: +11.8% · 3M: -30.3%

Current Technical Phase

ORGN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -27.3%), weak momentum, RSI 34

RSI (14): 33.5 · Price: $0.95

BAK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.5 · Price: $1.70

Fundamentals Snapshot

Metric ORGN BAK
Market Cap — —
Forward P/E -3.1 -1.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.9% 0.2%
Gross Margin 0.0% 0.1%
Operating Margin -34.6% 0.2%
EPS -48.43 -2.60
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ORGN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.